Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II study

Clin Neurol Neurosurg. 1995 May;97(2):139-41. doi: 10.1016/0303-8467(95)00023-d.

Abstract

The efficacy of Org 2766, an ACTH(4-9) analogue, on the recovery of cisplatin neuropathy of longstanding duration was investigated in a phase II study. Twenty-two patients were treated with Org 2766 during a period of 4 months and vibration perception threshold (VPT) and sum scores for neuropathic symptoms and signs were compared with pre-treatment values. No change in VPT could be detected. Although there was a small improvement of clinical measures for neuropathy, no clear evidence for repair could be obtained. These results indicate no beneficial effect of Org 2766 on recovery of a longstanding cisplatin neuropathy.

Publication types

  • Comparative Study

MeSH terms

  • Adrenocorticotropic Hormone / administration & dosage
  • Adrenocorticotropic Hormone / analogs & derivatives*
  • Adrenocorticotropic Hormone / therapeutic use
  • Adult
  • Aged
  • Anticonvulsants*
  • Brain Diseases / drug therapy*
  • Brain Diseases / etiology*
  • Brain Diseases / physiopathology
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects*
  • Cisplatin / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Motion Perception
  • Neoplasms / drug therapy*
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / therapeutic use*
  • Prospective Studies
  • Treatment Outcome
  • Vibration

Substances

  • Anticonvulsants
  • Peptide Fragments
  • Org 2766
  • Adrenocorticotropic Hormone
  • Cisplatin